Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
Background: Pirfenidone was approved by the European Medicines Agency and introduced in most European countries in 2011 for treatment of idiopathic pulmonary fibrosis (IPF). Objective: To describe the national Danish experiences of pirfenidone treatment for IPF during 30 months with respect to targe...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2016-09-01
|
| Series: | European Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | http://www.ecrj.net/index.php/ecrj/article/view/32608/48669 |